Spinal Cord Infections

Neurologic Clinics

Volumn 31, Issue 1, 2013, Pages 19-53

  Richie, Megan B ^a   Pruitt, Amy A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Epidural abscess; HIV AIDS related myelopathy; Myelitis; Potts disease; Varicella zoster virus; West Nile virus

Indexed keywords

ACICLOVIR; BEVACIZUMAB; C REACTIVE PROTEIN; CARMUSTINE; CISPLATIN; CORTICOSTEROID; CYTARABINE; EPSTEIN BARR VIRUS ANTIGEN 1; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M; METHOTREXATE; METHYLPREDNISOLONE; THIOTEPA; TUMOR NECROSIS FACTOR ALPHA; VARICELLA ZOSTER VACCINE;

AFGHANISTAN; ASEPTIC MENINGITIS; ASPERGILLUS; ASTROCYTOMA; BLOOD CULTURE; BONE METASTASIS; BROWN SEQUARD SYNDROME; CANCER PATIENT; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CHICKENPOX; COMPLEMENT FIXATION TEST; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; CONTRAST ENHANCEMENT; CRYPTOCOCCUS; CYTOMEGALOVIRUS; DELAYED DIAGNOSIS; DEMOGRAPHY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDURAL ABSCESS; EPSTEIN BARR VIRUS; ERYTHROCYTE SEDIMENTATION RATE; ESCHERICHIA COLI; FLACCID PARALYSIS; FLAVIVIRUS INFECTION; FLOW CYTOMETRY; FOLLOW UP; GUILLAIN BARRE SYNDROME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HERPES ZOSTER; HOSPITAL INFECTION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMIGRATION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INDIA; LEUKOCYTE COUNT; LYME DISEASE; LYMPHOCYTE FUNCTION; MENINGOENCEPHALITIS; MIXED INFECTION; MORBIDITY; MYCOBACTERIUM TUBERCULOSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROCYSTICERCOSIS; NEUROSYPHILIS; NIGERIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEITIS; PAKISTAN; PARANEOPLASTIC NEUROPATHY; PARESTHESIA; PHYSICAL EXAMINATION; PLASMACYTOMA; PLASMAPHERESIS; PLEOCYTOSIS; POLIOMYELITIS; POLYMERASE CHAIN REACTION; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; REVIEW; SAUDI ARABIA; SCHISTOSOMIASIS; SENSITIVITY AND SPECIFICITY; SIDEROSIS; SPINAL CORD COMPRESSION; SPINAL CORD DECOMPRESSION; SPINAL CORD DISEASE; SPINAL CORD INFECTION; SPINAL CORD ISCHEMIA; SPINOTHALAMIC TRACT; STAPHYLOCOCCUS AUREUS; TABES DORSALIS; TOXOPLASMOSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TROPICAL SPASTIC PARAPARESIS; UREA NITROGEN BLOOD LEVEL; VARICELLA ZOSTER VIRUS; VENEREAL DISEASE REACTION TEST; VERTEBRA BODY; WEST NILE FLAVIVIRUS; WESTERN BLOTTING; ZOSTER SINE HERPETE;

HUMANS; INFECTION; MAGNETIC RESONANCE IMAGING; SPINAL CORD DISEASES;

EID: 84870232377     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2012.09.006     Document Type: Review

References (186)

1. Prasad S., Brown M.J., Galetta S.L. Transient downbeat nystagmus from West Nile virus encephalomyelitis. Neurology 2006, 66(2):1599-1600.
2. Wong S.H., Boggild M., Enevoldson T.P., et al. Myelopathy but normal MRI: where next?. Pract Neurol 2008, 8:90-102.
3. O'Sullivan C.E., Aksamit A.J., Harrington J.R., et al. Clinical spectrum and laboratory characteristics associated with detection of herpes simplex virus DNA in cerebrospinal fluid. Mayo Clin Proc 2003, 78:1347-1352.
4. Schmalstieg W.F., Weinshenker B.G. Approach to acute or subacute myelopathy. Neurology 2010, 75(Suppl 1):S2-S8.
5. Debette S., de Seze J., Pruvo J.P., et al. Long-term outcomes of acute and subacute myelopathies. J Neurol 2009, 256:980-988.
6. Graber J.J., Nolan C.P. Myelopathies in patients with cancer. Arch Neurol 2010, 67(3):298-304.
7. Kumar N. Superficial siderosis: associations and therapeutic implications. Arch Neurol 2007, 64:491-496.
8. Flanagan E.P., McKeon A., Lennon V.A., et al. Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology 2011, 76(24):2089-2095.
9. Bernal-Caso F., Joseph J.T., Koralnik I.J. Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immune deficiency syndrome patient. J Neurovirol 2007, 13:474-476.
10. Takeda S., Yamazaki K., Miyakaawa T., et al. Progressive multifocal leukoencephalopathy showing extensive spinal cord involvement in a patient with lymphocytopenia. Neuropathology 2009, 29:485-493.
11. Sakai M., Ohashi K., Ohta K., et al. Immune-mediated myelopathy following allogeneic stem cell transplantation. Int J Hematol 2006, 84(3):272-275.
12. Matsuo Y., Kamezaki K., Takeishi S., et al. Encephalomyelitis mimicking multiple sclerosis associated with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Intern Med 2009, 48(16):1453-1456.
13. Armstrong R.J., Elston J.S., Hatton C.S., et al. De novo relapsing-remitting multiple sclerosis following autologous stem cell transplantation. Neurology 2010, 75(1):89-91.
14. Devries A.S., Harper J., Murray A., et al. Vaccine-derived poliomyelitis 12 years after infection in Minnesota. N Engl J Med 2011, 364(24):2316-2323.
15. Buell J.F., Gross T.G., Hanaway M.J., et al. Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc 2005, 37:954-955.
16. Cavaliere R., Petroni G., Lopes M.B., et al. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Cancer 2010, 116:863-870.
17. Hamadani M., Mratin L.K., Benson D.M., et al. Central nervous systems post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR. Bone Marrow Transplant 2007, 39:249-251.
18. Nabors L.B., Palmer C.A., Julian B.A., et al. Isolated central nervous system post-transplant lymphoproliferative disorder treated with high-dose intravenous methotrexate. Am J Transplant 2009, 9:1243-1248.
19. Ahmad I., Cau N.V., Kwan J., et al. Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation. Transplantation 2009, 87:1240-1245.
20. Evens A.M., Roy R., Sterrenberg D., et al. Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy. Curr Oncol Rep 2010, 12:383-394.
21. Bandyopadhyay S.K., Bandyopdhyay R., Dutta A. Profile of tuberculous meningitis with or without HIV infection and the predictors of adverse outcome. West Indian Med J 2009, 58(6):589-592.
22. Vinnard C., Macgregor R.R. Tuberculous meningitis in HIV-infected individuals. Curr HIV/AIDS Rep 2009, 6(3):139-145.
23. Cecchini D., Ambrosioni J., Brezzo C., et al. Tuberculous meningitis in HIV-infected and non-infected patients: comparison of cerebrospinal fluid findings. Int J Tuberc Lung Dis 2009, 13(2):269-271.
24. Cerny R., Machla L., Bojar M., et al. Neuroborreliosis in an HIV-1 positive patient. Infection 2006, 34(2):100-102.
25. Nissapatorn V., Sawangjaroen N. Parasitic infections in HIV infected individuals: diagnostic and therapeutic challenges. Indian J Med Res 2011, 134(6):878-897.
26. Thurnher M.M., Post M.J., Jinkis J.R. MRI of infections and neoplasms of the spine and spinal cord in 55 patients with AIDS. Neuroradiology 2000, 42(8):551-563.
27. Hogan C., Wilkins E. Neurological complications in HIV. Clin Med 2011, 11(6):571-575.
28. Taber K.H., Hayman L.A., Shandera W.X., et al. Spinal disease in neurologically symptomatic HIV-positive patients. Neuroradiology 1999, 41(5):360-368.
29. Berger J.R. Infectious myelopathies. Continuum (Minneap Minn) 2011, 17(4):761-775.
30. Guiot H.M., Pita-Garcia I.L., Bertran-Pasarell J., et al. Cytomegalovirus polyradiculomyelopathy in AIDS: a case report and review of the literature. P R Health Sci J 2006, 25(4):359-362.
31. Vyas R., Ebright J.R. Toxoplasmosis of the spinal cord in a patient with AIDS: case report and review. Clin Infect Dis 1996, 23(5):1061-1065.
32. Pinto A., Santos E., Correa D.F., et al. CMV and HSV-2 myeloradiculitis in an HIV infected patient. Rev Inst Med Trop Sao Paulo 2011, 53(3):173-175.
33. Aktipi K.M., Ravaglia S., Ceroni M., et al. Severe recurrent myelitis in patients with hepatitis C infection. Neurology 2007, 68(6):468-469.
34. Cinque P., Bossolasco S., Lundkvist A. Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system. J Clin Virol 2003, 26(1):1-28.
35. Boivin G. Diagnosis of herpesvirus infections of the central nervous system. Herpes 2004, 11(Suppl 2):48A-56A.
36. DiRocco A., Simpson D.M. AIDS-associated vacuolar myelopathy. AIDS Patient Care STDS 1998, 12(6):457-461.
37. Fauci A.S., Lane H.C. HIV neurology. Harrison's neurology in clinical medicine 2010, 493-506. McGraw Hill, New York. 2nd edition. S.L. Hauser, S.A. Josephson (Eds.).
38. Silva M.T., Neves E.S., Grinsztejn B., et al. Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1. AIDS 2012, 26:521-522.
39. Casseb J., de Oliveria A.C., Vergara M.P., et al. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM-like) among HIV-1-infected patients. J Med Virol 2008, 80(3):392-398.
40. Tulius Silva M., De Melo Espindola O., Bezerra Leit A.C., et al. Neurological aspects of human T lymphotropic virus coinfection. AIDS Rev 2009, 11(2):71-78.
41. Boulware D.R., Bonham S.C., Meya D.B., et al. Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome. J Infect Dis 2010, 202(6):962-970.
42. Clark B.M., Krueger R.G., Price P., et al. Compartmentalization of the immune response in varicella zoster virus immune restoration disease causing transverse myelitis. AIDS 2004, 18(8):1218-1221.
43. Tahir M., Sinha S., Sharma S.K., et al. Immune reconstitution inflammatory syndrome manifesting as disseminated tuberculosis, deep venous thrombosis, encephalopathy and myelopathy. Indian J Chest Dis Allied Sci 2008, 50(4):363-364.
44. Tyler K.L. Emerging viral infections of the CNS: parts I and II. Arch Neurol 2009, 66:939-958. 1065-74.
45. Moellering R.C. The growing menace of community acquired methicillin resistant Staphylococcus aureus. Ann Intern Med 2006, 144:368-370.
46. Pruitt A.A. Neurologic infectious disease emergencies. Neurol Clin 2012, 30(1):129-160.
47. Darouiche R.O. Spinal epidural abscess. N Engl J Med 2006, 35:2012-2020.
48. Pradilla G., Nagahama Y., Spivak A.M., et al. Spinal epidural abscess: current diagnosis and management. Curr Infect Dis Rep 2010, 12:484-491.
49. Huang P.Y., Chen S.F., Chang W.N., et al. Spinal epidural abscess in adults caused by Staphylococcus aureus: clinical characteristics and prognostic factors. Clin Neurol Neurosurg 2012, 114:572-576.
50. Moellering R.C., Abbott G.F., Ferraro M.J. Case records of the MGH. Case 2-2011: a 30-year-old woman with shock after treatment of a furuncle. N Engl J Med 2011, 364:266-275.
51. Vigil K.J., Johnson J.R., Johnston B.D., et al. E coli pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis 2010, 50:374-380.
52. Davis D.P., Salazar A., Chan T.C., et al. Prospective evaluation of a clinical decision guideline to diagnose spinal epidural abscess in patients who present to the emergency department with spine pain. J Neurosurg Spine 2011, 14:765-770.
53. Diehn F.E. Imaging of spine infection. Radiol Clin North Am 2012, 50:777-798.
54. Dörflinger-Hejlek E., Kirsch E.C., Reiter H., et al. Diffusion-weighted MR imaging of intramedullary spinal cord abscess. AJNR Am J Neuroradiol 2010, 31:1651-1652.
55. Reihsaus E., Waldaur H., Seeling W. Spinal epidural abscess: a meta-analysis of 915 patients. Neurosurg Rev 2000, 23:175-204.
56. Pradilla G., Ardila G.P., Hsu W., et al. Epidural abscesses of the CNS. Lancet Neurol 2009, 8:292-300.
57. Karikari I.O., Powers C.J., Reynolds R.M., et al. Management of a spontaneous spinal epidural abscess: a single-center 10-year experience. Neurosurgery 2009, 65:919-924.
58. Skaf G.S., Kanafani Z.A., Araj G.F., et al. Non-pyogenic infections of the spine. Int J Antimicrob Agents 2010, 36(2):99-105.
59. Garcia-Monco J.C. Central nervous system tuberculosis. Neurol Clin 1999, 17(4):737-759.
60. Ferrer M., Gutieerez Torres L., Ayala Ramirez O., et al. Tuberculosis of the spine. A systematic review of case series. Int Orthop 2010, 36(2):221-231.
61. Sree Harsha C.K., Shetty A.P., Rajasekaran S. Intradural spinal tuberculosis in the absence of vertebral or meningeal tuberculosis: a case repot. J Orthop Surg 2006, 14(1):71-75.
62. Drapkin M.S., Kamath R.S., Kim J.Y. Case 26-2012: a 70-year-old woman with fever and back pain. N Engl J Med 2012, 367:754-762.
63. Luo L., Pino J. An intradural extramedullary tuberculoma of the spinal cord in a non-HIV-infected patient: case report and review of the literature. Lung 2006, 184(3):187-193.
64. Dastur H.M. Diagnosis and neurosurgical treatment of tuberculous disease of the CNS. Neurosurg Rev 1983, 6(3):111-117.
65. Thwaites G., Fisher M., Hemingway C., et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 2009, 59(3):167-187.
66. Wasay M., Arif H., Khealani B., et al. Neuroimaging of tuberculous myelitis: analysis of ten cases and review of literature. J Neuroimaging 2006, 16(3):197-205.
67. Kaynar M.Y., Kocer N., Gencosmanoglu B.E., et al. Syringomyelia as a late complication of tuberculous meningitis. Acta Neurochir (Wien) 2000, 142(8):935-938. [discussion: 938-9].
68. Muthukumar N., Sureshkumar V. Concurrent syringomyelia and intradural extramedullary tuberculoma as late complications of tuberculous meningitis. J Clin Neurosci 2007, 14(12):1225-1230.
69. Roca B. Intradural extramedullary tuberculoma of the spinal cord; a review of reported cases. J Infect 2005, 50(5):425-431.
70. Mohit A.A., Santiago P., Rostomily R. Intramedullary tuberculoma mimicking primary CNS lymphoma. J Neurol Neurosurg Psychiatry 2004, 75(11):1636-1638.
71. Kung D.H., Hubenthal E.A., Kwan J.Y., et al. Toxoplasmosis myelopathy and myopathy in an AIDS patient: a case of immune reconstitution inflammatory syndrome?. Neurologist 2011, 17(1):49-51.
72. Hernandez-Albujar S., Arribas J.R., Royo A., et al. Tuberculous radiculomyelitis complicating tuberculous meningitis: case report and review. Clin Infect Dis 2000, 30(6):915-921.
73. Kayaoglu C.R., Tuzun Y., Boga Z., et al. Intramedullary spinal tuberculoma: a case report. Spine 2000, 25(17):2265-2268.
74. Sinha S., Shekhar R.C., Singh G., et al. Early versus delayed initiation of antiretroviral therapy for Indian HIV-infected individuals with tuberculosis on anti-tuberculosis treatment. BMC Infect Dis 2012, 12(1):168.
75. Charles V., Duprez T.P., Kabamba B., et al. Poliomyelitis-like syndrome with matching magnetic resonance features in a case of Lyme neuroborreliosis. J Neurol Neurosurg Psychiatry 2007, 78(10):1160-1161.
76. Halperin J.J. Neurologic manifestations of Lyme disease. Curr Infect Dis Rep 2011, 13:360-366.
77. Schmidt C., Plate A., Angele B., et al. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology 2011, 76(12):1051-1058.
78. Bigi S., Aebi C., Nauer C., et al. Acute transverse myelitis in Lyme neuroborreliosis. Infection 2010, 38(5):413-416.
79. Hattingen E., Weidauer S., Kieslich M., et al. MR imaging in neuroborreliosis of the cervical spinal cord. Eur Radiol 2004, 14(11):2072-2075.
80. Chilver-Stainer L., Fischer U., Hauf M., et al. Syphilitic myelitis: rare, nonspecific, but treatable. Neurology 2009, 72:673-675.
81. Marra C.M., Maxwell C.L., Smith S.L., et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004, 189:369-376.
82. Kumar D., Drebot M.A., Wong S.J., et al. A seroprevalence study of West Nile virus infection in solid organ transplant recipients. Am J Transplant 2004, 4:1883.
83. Levi M.E., Quan D., Ho J.T., et al. Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients. Clin Transplant 2010, 24:223-238.
84. Leis A.A., Stokic D.S. Neuromuscular manifestations of West Nile virus infection. Front Neurol 2012, 3:1-16.
85. Khetsuriani N., Prevots D.R., Quick L., et al. Persistence of vaccine-derived poliovirus among immunodeficient persons with vaccine-associated paralytic poliomyelitis. J infect Dis 2003, 188(12):1845-1852.
86. Hosada M., Inoue H., Miyazawa Y. Vaccine associated paralytic poliomyelitis in Japan. Lancet 2012, 379:520.
87. Aylward B., Yamad T. The polio endgame. N Engl J Med 2011, 364(24):2273-2275.
88. Centers for Disease Control and Prevention (CDC) Update on vaccine-derived polioviruses-worldwide, July 2009-March 2011. MMWR Morb Mortal Wkly Rep 2011, 60(25):846-850.
89. Saeed M., Zaidi S.Z., Naeem A., et al. Epidemiology and clinical findings associated with enteroviral acute flaccid paralysis in Pakistan. BMC Infect Dis 2007, 7:6.
90. Rahimi P., Tabatabaie H., Gouya M.M., et al. Direct identification of non-polio enteroviruses in residual paralysis cases by analysis of VP1sequences. J Clin Virol 2009, 45(2):139-141.
91. Yang T.T., Huang L.M., Lu C.Y., et al. Clinical features and factors of unfavorable outcomes for non-polio enterovirus infection of the central nervous system in northern Taiwan, 1994-2003. J Microbiol Immunol Infect 2005, 38(6):417-424.
92. Gharbi J., Jaidane H., Ben M'hadheb M., et al. Epidemiological study of non-polio enterovirus neurological infections in children in the region of Monastir, Tunisia. Diagn Microbiol Infect Dis 2006, 54(1):31-36.
93. Junttila N., Leveque N., Kabue J.P., et al. New enteroviruses, EV-93 and EV-94, associated with acute flaccid paralysis in the Democratic Republic of the Congo. J Med Virol 2007, 79(4):393-400.
94. Nagel M.A., Gilden D.H. The protean neurologic manifestations of varicella-zoster virus infection. Cleve Clin J Med 2007, 74:489-494.
95. Curtis J.R., Patkar N., Xie A., et al. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum 2007, 56(4):1125-1133.
96. Brassard P., Kezouh A., Suissa S. Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis 2006, 43(6):717-722.
97. Strangfeld A., Listing J., Herzer P., et al. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-α agents. JAMA 2009, 301(7):737-744.
98. Javed S., Javed S.A., Tyring S.K. Varicella vaccines. Curr Opin Infect Dis 2012, 25:135-140.
99. Gilden D., Cohrs R.J., Mahalingam R., et al. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009, 8:731-740.
100. Gilden D., Nagel M.A., Ransooff R.M., et al. Recurrent varicella zoster virus myelopathy. J Neurol Sci 2009, 276(1-2):196-198.
101. Cortese A., Tavazzi E., Delbue S., et al. Varicella zoster virus-associated polyradiculoneuritis. Neurology 2009, 73(16):1334-1335.
102. Mathews M.S., Sorkin G.C., Brant-Zawadzki M., et al. Varicella zoster infection of the brainstem followed by Brown-Sequard syndrome. Neurology 2009, 72(21):1874.
103. Nagel M.A., Cohrs R.J., Mahalingam R., et al. The varicella zoster virus vasculopathies: clinical, CSF, imaging and virologic features. Neurology 2008, 70:853-860.
104. Young-Barbee C., Hall D.A., LoPresti J.J. Brown Sequard syndrome after herpes zoster. Neurology 2009, 72:670-671.
105. Wolf J., Nagel M.A., Mahalingam R., et al. Chronic active varicella zoster virus infection. Neurology 2012, 79:828-829.
106. Majid A., Galetta S.L., Sweeney C.J., et al. Epstein-Barr virus myeloradiculitis and encephalomyeloradiculitis. Brain 2002, 125:159-165.
107. Sanefuji M., Ohga S., Kira R., et al. Epstein Barr virus-associated meningoencephalomyelitis; intrathecal reactivation of the virus in an immunocompetent child. J Child Neurol 2008, 23(9):1072-1077.
108. Ross A.G., Bartley P.B., Adrian C.S., et al. Schistosomiasis. N Engl J Med 2002, 346:1212-1220.
109. Ferrari T.C., Moreira P.R. Neuroschistosomiasis: clinical symptoms and pathogenesis. Lancet Neurol 2011, 10:853-864.
110. Camargos S.T., Dantas F.R., Teixeira A.L. Schistosomal myelopathy mimicking spinal cord neoplasm. Scand J Infect Dis 2005, 37(5):365-367.
111. Ross A.G., Vickers D., Olds G.R., et al. Katayama syndrome. Lancet Infect Dis 2007, 7:218-224.
112. Ross A.G., McManus D.P., Farrar J., et al. Neuroschistosomiasis. J Neurol 2012, 259(1):22-32.
113. Garcia H.H., Del Brutto O.H. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 2005, 4:653-661.
114. Callacondo D., Garcia H.H., Gonzales I., et al. High frequency of spinal involvement in patients with basal subarachnoid neurocysticercosis. Neurology 2012, 78:1394-1400.
115. Lambertucci J.R., Vale T.C., Pereira A.C., et al. Isolated cervical spinal cord cysticercosis. Neurology 2011, 77(23):e138.
116. Boulos M.I., Aviv R.I., Lee L. Spinal neurocysticercosis manifesting as recurrent aseptic meningitis. Can J Neurol Sci 2010, 37:878-880.
117. Venna N., Coyle C.M., Gonzalez R.G., et al. Case 25-2012: a 48 year old woman with diplopia, headaches, and papilledema. N Engl J Med 2012, 366:1924-1934.
118. Proano J.H., Torres-Corzo J., Rodriguez-DellaVecchia R., et al. Intraventricular and subarachnoid basal cisterns neurocysticercosis: a comparative study between traditional treatment versus neuroendoscopic surgery. Childs Nerv Syst 2009, 25:1467-1475.
119. Ersahin Y. Spinal epidural abscess: a meta-analysis of 915 patients. Neurosurg Rev 2001, 24(2-3):156.
120. Lury K., Smith J.K., Castillo M. Imaging of spinal infections. Semin Roentgenol 2006, 41(4):363-379.
121. Mantieene C., Albucher J.F., Catalaa I., et al. MRI in Lyme disease of the spinal cord. Neuroradiology 2001, 43(6):485-488.
122. Meurs L., Labeye D., Declercq I., et al. Acute transverse myelitis as a main manifestation of early stage II neuroborreliosis in two patients. Eur Neurol 2004, 52(3):186-188.
123. Chang B.L., Shih C.M., Ro L.S., et al. Acute neuroborreliosis with involvement of the central nervous system. J Neurol Sci 2012, 295(1-2):10-15.
124. Tsiodras S., Kelesidis I., Kelesidis T., et al. Central nervous system manifestations of Mycoplasma pneumoniae infections. J Infect 2005, 51(5):343-354.
125. Tsiodras S., Kelesidis T., Kelesidis I., et al. Mycoplasma pneumoniae-associated myelitis: a comprehensive review. Eur J Neurol 2006, 13(2):112-124.
126. Moghtaderi A., Alavi-Naini R. Tuberculous radiculomyelitis: review and presentation of five patients. Int J Tuberc Lung Dis 2003, 7(12):1186-1190.
127. Suda S., Ueda M., Komaba Y., et al. Tuberculous myelitis diagnosed by elevated adenosine deaminase activity in cerebrospinal fluid. Clin Neurosci 2008, 15(9):1068-1069.
128. Arora S., Kumar R. Tubercular spinal epidural abscess involving the dorsal-lumbar region without osseous involvement. J Infect Dev Ctries 2011, 5(7):544-549.
129. Centers for Disease Control Updated guidelines for the sue of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep 2009, 58:7-10.
130. Toledano R., Lopez-Sendon J., Gilo F., et al. Posterior horn varicella-zoster virus myelitis. J Neurol 2007, 254(3):400-401.
131. Tavazzi E., Minoli L., Ferrante P., et al. Varicella zoster virus meningo-encephalo-myelitis in an immunocompetent patient. Neurol Sci 2008, 29(4):279-283.
132. Haug A., Mahalingam R., Cohrs R.J., et al. Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system. Case report and review of the literature. J Neurol Sci 2010, 292(1-2):85-88.
133. Lee C.C., Wu J.C., Huang W.C., et al. Herpes zoster cervical myelitis in a young adult. J Chin Med Assoc 2010, 73(11):605-610.
134. Sejvar J.J., Leiss A.A., Stokic D.S., et al. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 2003, 9(7):788-793.
135. Jeha L.E., Sila C.A., Lederman R.J., et al. West Nile virus infection: a new acute paralytic illness. Neurology 2003, 61(1):55-59.
136. Li J., Loeb J.A., Shy M.E., et al. Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. Ann Neurol 2003, 53(6):703-710.
137. Kleinschmidt-DeMasters B.K., Marder B.A., Levi M.E., et al. Naturally acquired West Nile virus encephalomyelitis in transplant recipients. Arch Neurol 2004, 61(8):1210-1220.
138. Ali M., Safriel Y., Sohi J., et al. West Nile virus infection: MR imaging findings in the nervous system. AJNR AM J Neuroradiol 2005, 26(2):289-297.
139. Lenzi M.E., Cuzzi-Maya T., Oliveira A.L., et al. Dermatological findings of human T lymphotropic virus type 1 (HTLV-I)-associated myelopathy/tropical spastic paraparesis. Clin Infect Dis 2003, 36(4):507-513.
140. Grindstaff P., Gruener G. The peripheral nervous system complications of HTLV-1 myelopathy (HAM/TSP) syndromes. Semin Neurol 2005, 25(3):315-327.
141. Bagnato F., Butman J.A., Mora C.A., et al. Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis. J Neurovirol 2005, 11(6):525-534.
142. Umehara F., Nose H., Saito M., et al. Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy. J Neurovirol 2007, 13(3):260-267.
143. Delgado S.R., Sheremata W.A., Brown A.D., et al. Human T-lymphotropic virus type I or II (HTLV-I/II) associated with recurrent longitudinally extensive transverse myelitis (LETM): two case reports. J Neurovirol 2010, 16(3):249-253.
144. Whiteman M.L., Dandapani B.K., Shebert R.T., et al. MRI of AIDS-related polyradiculomyelitis. J Comput Assist Tomogr 1994, 18(1):7-11.
145. Giobbia M., Carniato A., Scotton P.G., et al. Cytomegalovirus-associated transverse myelitis in a non-immunocompromised patient. Infection 1999, 27(3):228-230.
146. Maschke M., Kastrup O., Diener H.C. CNS manifestations of cytomegalovirus infections: diagnosis and treatment. CNS Drugs 2002, 16(5):303-315.
147. Fux C.A., Pfister S., Nohl F., et al. Cytomegalovirus-associated acute transverse myelitis in immunocompetent adults. Clin Microbiol Infect 2003, 9(12):1187-1190.
148. Rigamonti A., Usai S., Ciusani E., et al. Atypical transverse myelitis due to cytomegalovirus in an immunocompetent patient. Neurol Sci 2005, 26(5):351-354.
149. Wong M., Connolly A.M., Noetzel M.J. Poliomyelitis-like syndrome associated with Epstein-Barr virus infection. Pediatr Neurol 1999, 20(3):235-237.
150. Muhlau M., Bulow S., Stimmer H., et al. Seronegative Epstein-Barr virus myeloradiculitis in an immunocompetent 72-year-old woman. Neurology 2005, 65(8):1329-1330.
151. Paz J.A., Vallada M.G., Marques S.N., et al. Vaccine-associated paralytic poliomyelitis: a case report of domiciliary transmission. Rev Hosp Clin Fac Med Sao Paulo 2000, 55(3):101-104.
152. Asahina N., Matsunami Y., Sueda K., et al. Vaccine-associated paralytic poliomyelitis in a non-immunocompromised infant. Pediatr Int 2010, 52(5):838-841.
153. Ferraz-Filho J.R., dos Santos Torres U., de Oliveira E.P., et al. MRI findings in an infant with vaccine-associated paralytic poliomyelitis. Pediatr Radiol 2010, 40(Suppl 1):S138-S140.
154. Grewal A.K., Lopes M.B., Berg C.L., et al. Recurrent demyelinating myelitis associated with hepatitis C viral infection. J Neurol Sci 2004, 224(1-2):101-106.
155. Acharya J.N., Pacheco V.H. Neurologic complications of hepatitis C. Neurology 2008, 14(3):151-156.
156. Stubgen J.P. Immune-mediated myelitis associated with hepatitis virus infections. J Neuroimmunol 2011, 239(1-2):21-27.
157. Shyu W.C., Lin J.C., Chang B.C., et al. Recurrent ascending myelitis: an unusual presentation of herpes simplex virus type 1 infection. Ann Neurol 1993, 34(4):625-627.
158. Nakajima H., Furutama D., Kimura F., et al. Herpes simplex virus myelitis: clinical manifestations and diagnosis by the polymerase chain reaction method. Eur Neurol 1998, 39(3):163-167.
159. Azuma K., Yoshimoto M., Nishimura Y., et al. Herpes simplex virus type 1 myelitis with a favorable outcome. Intern Med 2001, 40(10):1068-1069.
160. Gobbi C., Tosi C., Stadler C., et al. Recurrent myelitis associated with herpes simplex virus type 2. Eur Neurol 2001, 46(4):215-218.
161. Eberhardt O., Kuker W., Dichgans J., et al. HSV-2 sacral radiculitis (Elsberg syndrome). Neurology 2004, 63(4):758-759.
162. Mohanty A., Venkatrama S.K., Das S., et al. Spinal intramedullary cysticercosis. Neurosurgery 1997, 40(1):82-87.
163. Leite C.C., Jinkins J.R., Escobar B.E., et al. MR imaging of intramedullary and intradural-extramedullary spinal cysticercosis. AJR Am J Roentgenol 1997, 169(6):1713-1717.
164. Mohanty A., Das S., Kolluri V.R., et al. Spinal extradural cysticercosis: a case report. Spinal Cord 1998, 36(4):285-287.
165. Gaur V., Gupta R.K., Dev R., et al. MR imaging of intramedullary spinal cysticercosis: a report of two cases. Clin Radiol 2000, 55(4):311-314.
166. Parmar H., Shah J., Patwardhan V., et al. MR imaging in intramedullary cysticercosis. Neuroradiology 2001, 43(11):961-967.
167. Sheehan J.P., Sheehan J., Lopes M.B., et al. Intramedullary spinal cysticercosis. Case report and review of the literature. Neurosurg Focus 2002, 12(6):e10.
168. Alsina G.A., Johnson J.P., McBride D.Q., et al. Spinal neurocysticercosis. Neurosurg Focus 2002, 12(6):e8.
169. Paterakis K.N., Kapsalaki E., Hadjigeorgiou G.M., et al. Primary spinal intradural extramedullary cysticercosis. Surg Neurol 2007, 68(3):309-311. [discussion: 312].
170. Goncalves F.G., Neves P.O., Jovem C.L., et al. Chronic myelopathy associated to intramedullary cysticercosis. Spine 2010, 35(5):E159-E162.
171. Del Brutto O.H. Neurocysticercosis: a review. ScientificWorldJournal 2012, 2012:159821.
172. Junker J., Eckardt L., Husstedt I. Cervical intramedullar schistosomiasis as a rare cause of acute tetraparesis. Clin Neurol Neurosurg 2001, 103(1):39-42.
173. Moreno-Carvalho O.A., Nascimento-Carvalho C.M., Bacelar A.L., et al. Clinical and cerebrospinal fluid (CSF) profile and CSF criteria for the diagnosis of spinal cord schistosomiasis. Arq Neuropsiquiatr 2003, 61(2B):353-358.
174. Carod Artal F.J., Vargas A.P., Horan T.A., et al. Schistosoma mansoni myelopathy: clinical and pathologic findings. Neurology 2004, 63(2):388-391.
175. Saleem S., Belal A.I., el-Ghandour N.M. Spinal cord schistosomiasis: MR imaging appearance with surgical and pathologic correlation. AJNR Am J Neuroradiol 2005, 26(7):1646-1654.
176. Nascimento-Carvalho C.M., Moreno-Carvalho O.A. Neuroschistosomiasis due to Schistosoma mansoni: a review of pathogenesis, clinical syndromes and diagnostic approaches. Rev Inst Med Trop Sao Paulo 2005, 47(4):179-184.
177. Carod-Artal F.J. Neurological complications of Schistosoma infection. Trans R Soc Trop Med Hyg 2008, 102(2):107-116.
178. Jiang Y.G., Zhang M.M., Xiang J. Spinal cord schistosomiasis japonica: a report of 4 cases. Surg Neurol 2008, 69(4):392-397.
179. de Jongste A.H., Tilanus A.M., Bax H., et al. New insights in diagnosing Schistosoma myelopathy. J Infect 2010, 60(3):244-247.
180. Poon T.P., Tchertkoff V., Pares G.F., et al. Spinal cord toxoplasma lesion in AIDS: MR findings. J Comput Assist Tomogr 1992, 16(5):817-819.
181. Lortholary O., Lisovoski F., Brechot J.M., et al. Myelitis due to Toxoplasma gondii in a patient with AIDS. Clin Infect Dis 1994, 19(6):1167-1168.
182. Cosan T.E., Kabukcuoglu S., Arslantas A., et al. Spinal toxoplasmic arachnoiditis associated with osteoid formation: a rare presentation of toxoplasmosis. Spine 2001, 26(15):1726-1728.
183. Straathof C.S., Kortbeek L.M., Roerdink H., et al. A solitary spinal cord toxoplasma lesion after peripheral stem-cell transplantation. J Neurol 2001, 248(9):814-815.
184. Schnepper G.D., Johnson W.D. Recurrent spinal hydatidosis in North America. Case report and review of the literature. Neurosurg Focus 2004, 17(6):E8.
185. Sapkas G.S., Machinis T.G., Chloros G.D., et al. Spinal hydatid disease, a rare but existent pathological entity: case report and review of the literature. South Med J 2006, 99(2):178-183.
186. Midyat L., Gokce S., Onder A., et al. A very rare cause of childhood paraparesis: primary intradural extramedullary spinal hydatid cyst. Pediatr Infect Dis J 2009, 28(8):754-755.